Clinical trial · no report yet · Phase 2
NCT03541850
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery
- NCT03541850 ↗
- Active, not recruiting
- Jonsson Comprehensive Cancer Center
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| X threads | 3 |
The trial
ClinicalTrials.gov- Official title
- Prospective Study of Stereotactic Body Radiotherapy (SBRT) Following Radical Prostatectomy
- Phase
- Phase 2
- Status
- Active, not recruiting
- Conditions
- PSA Level Greater Than 0.03; PSA Progression; Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7; Stage II Prostate Adenocarcinoma AJCC v7; Stage III Prostate Adenocarcinoma AJCC v7
- Interventions
- Antiandrogen Therapy; Quality-of-Life Assessment; Stereotactic Body Radiation Therapy
- Arms
- Treatment (SBRT, ADT) · Experimental
- Enrollment
- 92
- Primary outcomes
- Biochemical recurrence-free survival (BCRFS)
- Physician-scored toxicity
- Patient-reported toxicity outcomes EPIC-26
- Patient-reported toxicity outcomes IPSS
- Sponsor
- Jonsson Comprehensive Cancer Center with Viewray Inc.
- Start
- Jan 29, 2019
- Primary completion
- Nov 1, 2026 (estimated)
- Results posted
- No
- Registry record
- NCT03541850 · updated Nov 6, 2025
Publications
linked from the registry- Nikitas J, Ballas LK, Romero T, Lynch C, Ma TM, Valle LF, Sachdeva A, Chong N, Basehart V, Franco A, Reiter R, Saigal C, Chamie K, Litwin MS, Donin NM, Rettig M, Nickols NG, Cao M, Liauw SL, Steinberg ML, Kishan AU. Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical Trial. JAMA Oncol. 2025 Jul 1;11(7):726-734. doi: 10.1001/jamaoncol.2025.1059. PubMed 40372727
- Nikitas J, Smith LM, Gao Y, Ma TM, Sachdeva A, Yoon SM, Jiang T, Low DA, Ballas LK, Steinberg ML, Cao M, Kishan AU. The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial. Radiother Oncol. 2023 Jun;183:109631. doi: 10.1016/j.radonc.2023.109631. Epub 2023 Mar 18. PubMed 36934894